Indiana University


Cancer researchers discover new type of retinoblastoma in babies

March 13, 2013 -- Not all forms of retinoblastoma, a pediatric cancer of the eye, may be inherited, a discovery that would spare children years of medical evaluations and offer the potential of drug therapy for an aggressive malignancy.

Researchers say NSAIDs can boost stem cells for transplants for cancer patients

March 13, 2013 -- Scientists say that non-steroidal anti-inflammatory drugs may be a boon to doctors gathering stem cells for transplants to treat patients with blood or bone marrow cancers, including non-Hodgkin’s lymphoma and multiple myeloma.

Regenstrief and IU study investigates older adults' views on cancer screenings

March 11, 2013 -- A study from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many older adults are hesitant to halt cancer screenings even when the screenings may no longer be beneficial or may even be potentially harmful. The study is among the first to explore older adults’ perceptions of recommendations to halt screenings for breast, prostate, colon and other cancers as they age.

IU researchers earn $3.2 million grant to develop, improve therapies for pancreatic cancer

March 11, 2013 -- Two Indiana University researchers have been awarded a multi-year, $3.2 million grant to develop and improve therapies for pancreatic cancer, the fourth leading cause of cancer death in the United States.

IU physician researcher testing novel surgical technique for uterine, cervical cancer patients

January 24, 2013 -- A technique initially used to spare breast tissue during surgery is being researched by an Indiana University School of Medicine physician to improve prognosis, reduce complications and spare lymph nodes in women with gynecological cancer.

IU researcher’s lung cancer work may someday improve standard of care

January 23, 2013 -- Lung cancer researchers at Indiana University Melvin and Bren Simon Cancer Center are developing new anti-cancer agents that may someday improve the current standard of care.

Indiana University’s Corson named Outrun the Sun Melanoma Research Scholar

January 10, 2013 -- Timothy Corson, Ph.D., assistant professor of ophthalmology at the Eugene and Marilyn Glick Eye Institute, has been selected as one of two 2012 Outrun the Sun Melanoma Research Scholars. Corson is the first Indiana University researcher to receive this distinction.

IU Simon Cancer Center seeks high school, college applicants for 2013 Summer Research Program

December 6, 2012 -- High school and college students from underrepresented populations interested in cancer research careers can gain hands-on experiences during the 2013 Indiana University Melvin and Bren Simon Cancer Center Summer Research Program.

Inhibition of enzyme could lead to improved chemotherapy and stem cell transplant results

November 21, 2012 -- Blocking the action of one enzyme could mean improved results for thousands of cancer patients who undergo bone marrow or cord blood transplants after chemotherapy, an Indiana University research team has reported.

Komen Tissue Bank at IU Simon Cancer Center Reaches Milestone: 3,002 Women Donate Tissue

November 13, 2012 -- The world’s only known healthy breast tissue bank has set a milestone.

Indiana University researchers report first effective treatment of tumors arising from common genetic disease NF1

November 1, 2012 -- Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.

IU School of Medicine researcher receives lifetime achievement award from American Pancreatic Association

October 29, 2012 -- An Indiana University Melvin and Bren Simon Cancer Center researcher will be honored with a lifetime achievement award for his work in pancreatic cancer.

IU School of Medicine researcher: Genome Atlas finds future targets for breast cancer treatments

October 23, 2012 -- Scientists are now a step closer to understanding the complexities of breast cancer with findings made available through The Cancer Genome Atlas, a multi-center study funded by the National Institutes of Health. Indiana University School of Medicine participated in the research that identified four molecular cancer subtypes based on samples from 825 breast cancer patients.

IU research finds memory, thought-process training promising options for breast cancer symptom management

October 2, 2012 -- A new Indiana University study is the first of its kind to show it may be possible to improve memory and thought process speed among breast cancer survivors.

IU Simon Cancer Center’s Dr. Abonour cycling 200 miles in southeastern Indiana to raise funds, awareness of multiple myeloma

September 12, 2012 -- Unexplained tremendous back pain sent Pittsboro, Ind., resident Myron Gill to the doctor.

Dunnington to lead Indiana University School of Medicine Department of Surgery

September 6, 2012 -- Gary Dunnington, M.D., has been named chair of the Indiana University School of Medicine Department of Surgery.

Simple test for identifying childhood leukemia in Kenya goal of Indiana and Moi University cancer doctors

August 30, 2012 -- A unique idea to identify leukemia in children earlier in western Kenya has earned grant funding from Alex’s Lemonade Stand Foundation for Childhood Cancer for an Indiana University School of Medicine pediatrician.

IPS, American Cancer Society, and IU Simon Cancer Center summer program offers unique science learning experience for high school students

August 15, 2012 -- Eight students from Indianapolis Public Schools spent part of their summer vacation working alongside cancer physicians and researchers on the Indiana University School of Medicine campus.

IU researchers identify protein target that could lead to therapies for hard-to-treat cancers

July 23, 2012 -- Researchers at the Indiana University School of Medicine have identified a compound that targets a cancer-related protein, suggesting it could offer a future therapy for difficult-to-treat cancers.

IU research leads to risk factor test for rare chest cancers

June 4, 2012 -- Research conducted by physicians and scientists at the Indiana University School of Medicine has resulted in a genetic test to predict the risk of recurrence of thymoma, a rare tumor of the upper chest. The study results were presented June 2 in a poster presentation at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago.